Introduction
Actin polymerization plays a pivotal role in cell migration, polarization, cytokinesis, cell adhesions and shape changes, and is ultimately implicated in a variety of stages of tumor progression, in particular, metastasis. In mammalian cells, two types of actin filaments have been described with each showing distinct physiological functions. One type is branched actin filaments that are normally associated with cortical areas such as lamellipodia or membrane ruffles, the structures that are responsible for membrane protrusions and cell migration (Mullins et al., 1998; Borisy and Svitkina, 2000) . The other type is nonbranched actin filaments such as stress fibers that are frequently associated with focal adhesions, adherent junctions and filopodia. The assembly of each type of actin filaments is directed by distinct cellular machineries. Branched actin filaments are nucleated by Arp2/3 complex (Pollard et al., 2000) , whereas nonbranched actin filaments in focal adhesions and adherent junctions are assembled by formin family proteins (Evangelista et al., 2003) . The Arp2/3 complexmediated actin assembly involves an activation step, which requires the function of WASP family proteins and cortactin. WASP-related proteins are the targets of small GTPases such as Rac or Cdc42 (Pollard and Borisy, 2003) , whereas cortactin is the prominent substrate of Src protein tyrosine kinases (Wu and Parsons, 1993; Zhan et al., 1993) and is implicated in metastasis ). In the presence of both cortactin and WASP proteins, cortactin facilitates the release of activated WASP proteins from Arp2/3 complex at branching sites, promotes and stabilizes branched actin filaments (Weaver et al., 2001; Uruno et al., 2003) .
Missing in metastasis (MIM) is a putative metastatic suppressor and expressed at low levels in a subset of highly invasive tumor cells (Lee et al., 2002) . The predicted amino-acid sequence of MIM encodes a protein that contains multiple function motifs, including a coiled-coil domain, a lysine-rich domain (LRD), serine-rich domain (SRD), proline-rich domain (PRD) and a WH2 domain at its C-terminus (Figure 1 ). MIM also shares a certain homology with insulin receptor substrate p53 (IRSp53) in a region of 250 amino acids at the N-terminus (Yamagishi et al., 2004) . Studies with a short form of MIM protein containing the PRD and the WH2 domain demonstrated that MIM binds preferentially to the ATP-bound G-actin (Mattila et al., 2003) , and modulates negatively the rate of spontaneous actin polymerization in vitro (Mattila et al., 2003; Woodings et al., 2003) , presumably by sequestration of the G-actin available for actin assembly. However, the intrinsic physiological function of MIM is still unknown as a technical difficulty to obtain recombinant full-length MIM protein (Mattila et al., 2003; Woodings et al., 2003) . In this study, we found that MIM-green fluorescent protein (GFP) colocalizes with cortactin and interacts directly with the cortactin SH3 domain. Having successfully prepared recombinant full-length protein, we also demonstrated that MIM activates markedly cortactin but attenuates N-WASP-mediated actin polymerization. Furthermore, we found that overexpression of MIM inhibits cell motility in a manner depending on interaction with cortactin and G-actin. Therefore, this study suggests that MIM may be implicated in cell motility by modulating different actin polymerization factors.
Results

MIM binds to cortactin by targeting to cortactin SH3 domain
To examine the physiological function of MIM, we prepared a DNA fragment encoding a full-length murine MIM protein in retroviral vector MGIN (Cheng et al., 1997) , in which MIM was tagged by GFP at its C-terminus (MIM-GFP). Infection of the virus into NIH3T3 cells resulted in over 90% of cell population expressing MIM-GFP based on microscopic inspection (data not shown). Examination of the infected cells revealed that MIM-GFP localizes frequently in punctate structures in the cytoplasm, the pattern that is similar to that of cortactin (Liu et al., 1999) . Indeed, staining of cells with cortactin and GFP antibodies demonstrated that many MIM-GFP puncta were colocalized with cortactin (Figure 2a-c) . To verify the direct interaction between cortactin and MIM, the lysates of cells expressing MIM-GFP were subjected to immunoprecipitation with GFP antibody followed by immunoblot with cortactin antibody. This analysis showed that cortactin was readily precipitated in the immunopellet (Figure 2d , left panel). Furthermore, cortactin antibody was also able to precipitate MIM-GFP (Figure 2d , right panel), but not GFP (data not shown).
The direct interaction between cortactin and MIM-GFP was further verified by pull-down analysis using GST-cortactin ( Figure 2e , lane 3), which readily precipitated MIM-GFP in cell lysates. To examine the sequence of cortactin responsible for the interaction between cortactin and MIM-GFP, GST-CortDSH3 and GST-Cort-SH3 proteins were also analysed. While GST-Cort-SH3 was able to pull down MIM-GFP ( Figure 2e , lane 2), GST-CortDSH3 failed to do so (lane 1). Furthermore, MIMDPRD-GFP, a mutant with deletion of the sequence from 612 to 727 that contains two proline-rich stretches, is required for an optimal interaction between cortactin and MIM-GFP (Figure 2e , right panel). Taken together, these data demonstrate that the interaction between cortactin and MIM occurs between the cortactin SH3 domain and a proline-rich sequence of MIM.
MIM enhances cortactin-mediated actin polymerization
To evaluate the biochemical function of MIM, we made an effort to prepare full-length murine MIM proteins tagged by either 6 Â His or GST epitope in bacterial strain BL21-CodonPlus-RPLI, which contains extra copies of Arg, Pro and Leu tRNA genes. The rationale to use this strain is that Arg, Pro and Leu residues are apparently over-represented in the predicted MIM amino-acid sequence and may quickly exhaust the limited pool of their corresponding tRNAs in common Escherichia coli strains, resulting in lower level of expression (Makrides, 1996) . With this strain and affinity chromatography, we were able to prepare soluble His-MIM or GST-MIM proteins in a high yield with purity over 90% (Figure 3a) . On SDS-PAGE, His-MIM migrates at a position with an apparent molecular weight of 120 kDa, which is significantly larger than 82.4 kDa as predicted from a full-length cDNA, indicating that MIM may have an irregular configuration. Consistent with this, MIM-GFP expressed in cells has also a gel motility of 150 kDa (Figure 2e ), which is greater than 110 kDa predicted from the sequence.
To explore the functional significance of the interaction between MIM and cortactin, we evaluated the potential effect of His-MIM on the cortactin-mediated polymerization of pyrene-labeled G-actin as described previously (Uruno et al., 2001 ). In the presence of 100 nM cortactin and 100 nM Arp2/3 complex, approximately 300 s was required to reach a half maximal actin polymerization (Figure 3b ). In contrast, the same level of actin assembly was achieved within 95 s when 10 nM His-MIM was added. A further time-course analysis of the half-maximal stimulation (t 1/2 ) demonstrated that His-MIM was able to activate cortactin maximally at concentrations as low as 2 nM (Figure 3c ). Interestingly, His-MIM started to inhibit actin assembly at higher concentrations, suggesting that His-MIM may be able to sequestrate G-actin, a property shared by many G-actin binding proteins (Bubb et al., 1991; Safer et al., 1991) . Indeed, when His-MIM was evaluated in the absence of Arp2/3 complex and cortactin, it inhibited the rate of actin polymerization in a dose-dependent manner (Figure 3d ). At 800 nM, actin polymerization was nearly abolished. This inhibitory activity is similar to that of MIM-CT as described previously (Mattila et al., 2003; Woodings et al., 2003) . The role of the interaction between cortactin and MIM was evaluated with CortDSH3, which was unable to bind to MIM ( Figure 2e ). As shown in Figure 4a , His-MIM failed to enhance the activity of CortDSH3 within the concentration ranges, whereby it activated significantly wild-type cortactin (compared to Figure 3b ). Thus, direct binding to cortactin is necessary for MIM to activate cortactin.
Activation of cortactin-mediated actin polymerization requires full-length MIM
We also analysed the effect of His-MIM-CT, a short splicing variant of MIM that has been previously studied, on the cortactin-mediated actin polymerization. Unlike full-length MIM, His-MIM-CT showed no ability to promote the cortactin/Arp2/3-mediated actin polymerization at concentrations ranging from 10 to 100 nM ( Figure 4b ). However, it started to inhibit ) expressing MIM-GFP and glutathione Sepharose beads. After precipitation, the pellets were washed three times, fractionated by SDS-PAGE followed by immunoblot with GFP antibody. Lane 1, GST-CortDSH3; lane 2, GST-Cort-SH3; and lane 3, GST-cortactin. The position of MIM-GFP was indicated by an arrow. Right panel, GST-Cort-SH3 was used to pull down the lysates from NIH3T3 expressing MIM-GFP and MIMDPRD-GFP. The pellet was immunoblotted with anti-GFP antibody (upper panel). The relative expression levels of 3T3/MIM-GFP and 3T3/ MIMDPRD-GFP cells were shown in the bottom panel the actin polymerization at the concentration over 200 nM.
To examine why His-MIM-CT lacks the ability to activate cortactin, we examined its binding to cortactin. As shown in Figure 4c , His-MIM-CT binds to cortactin with an equilibrium dissociation constant (K d ) of 3770 nM, whereas His-MIM has a K d of 440 nM. Thus, His-MIM-CT is a poor cortactin binding protein.
MIM inhibits N-WASP-mediated actin polymerization in a G-actin binding-dependent manner
WASP and its related molecules are a protein family that activate Arp2/3 complex through recruiting G-actin to the complex (Pollard and Borisy, 2003) .
N-WASP-VCA, a constitutively activated form of N-WASP, stimulates potently Arp2/3 complex-mediated actin polymerization (Egile et al., 1999) . In the presence of 100 nM Arp2/3 complex and 5 nM N-WASP-VCA, His-MIM reduced significantly actin assembly at a concentration as low as 10 nM (Figure 5a ). At 60 nM, the rate of actin polymerization was reduced to a level close to that of actin alone. When a higher concentration (10 nM) of N-WASP-VCA was used, 200 nM His-MIM was needed to abolish the actin assembly (data not shown).
As both MIM and N-WASP-VCA contain a WH2 domain, which is a G-actin binding motif, we assumed a possible competition between N-WASP-VCA and MIM for G-actin. Indeed, both N-WASP-VCA and His-MIM Mouse full-length MIM was expressed as six consecutive histidine residues (6 Â His) fusion protein in BL21-CodonPlus (DE3)-RIPL-competent cells. Cells were grown in 2 l of Luria broth medium to OD 600 ¼ 0.6. Expression was induced by 0.6 mM isopropyl-b-D-1-thiogalactosidase and culture was incubated at 341C for additional 2 h. Bacterial pellets were collected, resuspended in 30 ml lysis buffer (50 mM NaH 2 PO 4 (pH 8.0), 300 mM NaCl, 10 mM imidazole, 1 mM PMSF and 0.2 mg/ml lysozyme), lysed by sonication and centrifuged at 14 000 r.p.m. for 20 min. His fusion proteins were isolated from the supernatant by incubation with 1.5 ml Ni-NTA beads (Qiagen). The beads were then washed three times with 50 mM NaH 2 PO 4 (pH 8.0), 300 mM NaCl, and 15 mM imidazole and packed in a plastic Poly-PreP chromatography column (Bio-Rad). His fusion proteins were eluted with 4 ml of elution buffer (50 mM NaH 2 PO 4 (pH 8.0), 300 mM NaCl and 100 mM imidazole). The eluted sample was exchanged to 50 mM Tris-HCl (pH 8.0) and 24 mM KCl by passing through a PD-10 column, further purified by Mono Q-Sepharose anion-exchange chromatography column in an HPLC system, and eluted with a linear gradient from 0.024 M to 1 M KCl. The peak fraction containing His-MIM was collected and dialysed against 5 mM Tris-HCl (pH 8.0) and 50 mM KCl. His-cortactin was prepared as described previously (Uruno et al., 2003) . (b) Polymerization of G-actin (10% pyrene labeled) was initiated in the presence of Arp2/3 (100 nM), cortactin (100 nM) and His-MIM at concentrations as indicated. The increase of pyrene fluorescence was detected as described previously (Uruno et al., 2001) . ( 
MIM modulates the agonist-induced cell motility in a manner depending on its interaction with cortactin and G-actin
The function of MIM in actin assembly implies that MIM may be involved in cell motility. Therefore, we examined the motility of NIH3T3 cells expressing MIM-GFP or GFP through Transwell, a modified Boyden chamber, under a condition with or without PDGF stimulation. In the absence of PDGF, no apparent difference in migration through Transwell was observed between the cells overexpressing MIM-GFP and the control cells expressing GFP only (Figure 6a ). PDGF stimulation resulted in approximately 100% increase in the motility of control cells (Figure 6a and b) . However, PDGF induced only 20% of the cells expressing MIM-GFP (Figure 6b ). In addition to NIH3T3 cells, we also examined the motility of human umbilical vein endothelial cells (HUVEC) infected with MIM-GFP viruses in response to sphingosine 1 phosphate (S1P), a potent chemotactant that triggered about twofold increase in the motility of HUVE cells expressing GFP alone (Figure 6c ). In contrast, S1P induced only 50% increase in the motility of the cells overexpressing MIM-GFP. Again, no significant difference was observed when the motility of cells expressing MIM-GFP was compared to the cells expressing GFP alone in the absence of S1P. Thus, overexpression of MIM antagonizes specifically extracellular stimuli-induced cell motility.
To evaluate the role of the interaction between cortactin and MIM in cell motility, we examined the motility of NIH3T3 cells expressing an MIM mutant MIMD(612-727)-GFP, which is deficient in cortactin (1) Actin alone His-MIM or His-MIM-CT were incubated for 2 h with GST-cortactin immobilized on glutathione beads at the concentrations as indicated. After brief centrifugation, aliquots of supernatants were subjected to SDS-PAGE followed by immunoblot using anti-MIM antibody. The blot was digitalized by film scanning and quantified by Scion Image software. The resulting digital data were used to fit a single rectangular hyperbola using Sigma Plot version 8.0, resulting in K d values as indicated binding. As shown in Figure 6d , the cells expressing the mutant migrated slightly less compared to control cells expressing GFP alone or the cells expressing MIM-GFP under the condition without PDGF treatment. More significantly, the cells responded poorly to PDGF for cell migration. On the basis of the ratio of the motility in the presence of PDGF to that in the absence of PDGF, the cells expressing MIM-GFP and GFP alone showed 40 and 110% response to PDGF, respectively, while the mutant overexpressors had only approximately 8% response (Figure 6e ). Thus, binding to cortactin substantiated the cell motility. We also analysed the motility of the cells expressing MIMDWH2-GFP mutant, which does not bind to Gactin and is not able to interfere with N-WASP-VCAmediated actin polymerization (Figure 5c ). Interestingly, these cells showed a 37% higher motility than the GFPexpressing cells under the condition with or without PDGF treatment (Figure 6d ), resulting in an apparent similar motility response to PDGF (Figure 6e ).
To confirm whether or not the apparent lower motility of the cells overexpressing MIM-GFP was the result of inhibition of the function of N-WASP, NIH3T3 cells were coinfected by viruses encoding N-WASP-GFP and MIM-GFP. The infected cells were then subjected to motility analysis. As shown in Figure 6f , either the cells overexpressing N-WASP-GFP alone or the cells coexpressing N-WASP-GFP and MIM-GFP showed a similar motility response to PDGF as the control cells. Thus, overexpression of N-WASP-GFP compromised inhibition of cell motility mediated by MIM.
Discussion
In this study, we provided evidence for the first time that full-length MIM has a dual function to modulate different types of Arp2/3 activators. It activates cortactin but antagonizes N-WASP-mediated actin polymerization as analysed in vitro. However, overexpression of MIM inhibited the motility of NIH3T3 and HUVE cells induced by their respective agonists, suggesting that the MIM-induced cortactin activation is overshadowed by its attenuation of N-WASP at least in overexpressing cells. Consistent with the suppression of the function of N-WASP, MIM-mediated cell motility inhibition was attenuated in the cells overexpressing N-WASP-GFP. Inhibition of N-WASP-VCA by MIM as manifested in vitro is likely due to a competition for G-actin because VCA and MIM have a very similar affinity for G-actin (Figure 5b) . Furthermore, an MIM mutant with deletion of the WH2 domain failed to inhibit N-WASP-VCA in vitro and cell motility in vivo (Figures 5c and 6d) . In fact, the rate of actin polymerization was slightly enhanced in the presence of the mutant without the WH2 domain at low concentrations. The reason for the enhancement is unclear. It may be due to other activities associated with different domains. Indeed, MIM also shows a strong affinity for F-actin as analysed in vitro (data not shown), the property that may stabilize nascent actin filaments at low concentrations. The same F-actin binding activity could also explain a slight inhibitory activity of the mutant at high concentrations (greater Comparison of the affinity of MIM and VCA for G-actin. G-actin (1.4 mM) was incubated with purified His-MIM or GST-VCA ranging from 0 to 1000 nM in the presence of either Ni-NTA beads or glutathione 4B beads at 41C. After 2 h of incubation, the samples were centrifuged. G-actin in the supernatant was detected by SDS-PAGE followed by Commassie blue staining. The intensity of G-actin bands was quantified and used to calculate K d values. (c) WH2 domain is required for MIM to inhibit VCA-mediated actin polymerization. The condition was the same as (a) except that His-MIMDWH2 was used than 60 nM) as shown in Figure 5c because the activity could prevent Arp2/3 complex from F-actin binding, which is essential for actin nucleation. Although our presented data suggest that N-WASP is a target of MIM in cells, MIM could also attenuate other WASP-related proteins such as WAVE/Scar proteins, which also contain a WH2 domain (Millard et al., 2004) . Determination of the intrinsic target of MIM in cells will require further efforts to dissect the specific role of MIM in the function of each member of the WASP family. MIM-mediated cortactin activation appears to be dependent on its ability to interact directly with the cortactin SH3 domain because it has no influence on a cortactin mutant without the SH3 domain (Figure 4a ). While this result indicates that binding to the SH3 domain is necessary for the activation of cortactinmediated actin polymerization, other data suggest that it is unlikely the sole mechanism. In fact, GST-tagged PRD motif of dynamin 2, which has a comparable affinity for cortactin as MIM, is unable to enhance the cortactin-mediated actin assembly (data not shown). Previous studies have shown that WIP, dynamin 2 and Fdg1, all of which contain a PRD and are able to bind to the cortactin SH3 domain, display a certain activity to promote the cortactin-mediated actin polymerization in vitro ( f Figure 6 Overexpression of MIM inhibits cell motility induced by PDGF. (a) NIH3T3 cells expressing either MIM-GFP or GFP were grown to 70% confluence and serum starved for overnight. The serum-starved cells were trypsinized, resuspended in DMEM and plated on the upper side of fibronectin-coated filters (pore size ¼ 8 mm) in Transwell at a density of 3 Â 10 4 cells/well. The lower chambers were filled with serum-free medium or the same medium containing PDGF (30 ng/ml). Cells were allowed to migrate for 6 h in a humidified incubator containing 5% CO 2 at 371C. Nonmigratory cells were removed from the top filter surface with a cotton swab. The cells migrated to the bottom surface were fixed in 4% paraformaldehyde in PBS for 30 min at room temperature, stained with Harris hematoxylin-modified solution for 30 min and viewed under a phase-contrast microscope ( Â 200 magnification). (b) For each sample as described in (a), digital images of five random microscopic fields were taken by Nikon camera equipped on the microscope and the number of migrated cells was counted using MetaMorph 6.1 program. Relative cell motility of each sample was calculated by comparison to the motility of the cells expressing GFP alone. (c) HUVE cells expressing MIM-GFP or GFP were quiescent in a low serum medium and analysed for cell motility as in (a) except M199 medium containing 0.5 mM S1P was used. (d) NIH3T3 cells infected with GFP, MIM-GFP, MIMDPRD-GFP and MIMDWH2-GFP viruses were analysed for the motility response to PDGF as described in (a) and (b). (e) Cell motility of each sample was represented as the ratio of the motility in the presence of PDGF to that without PDGF treatment. (f) NIH3T3 cells or cells expressing MIM-GFP were infected with a retrovirus encoding N-WASP-GFP. The infected cells were then subjected to motility assay as in (a) and the PDGF-stimulated motility was presented as in (e). All the data were shown as the means7s.d. of three independent experiments. *Po0.01 was calculated by paired t-test, referring to the difference between the indicated samples and the control sample (GFP) et al., 2004) . However, the extent to which these proteins activate cortactin is significantly different. Dynamin 2-mediated cortactin activation appears to be very modest. Based on the time to induce a half-maximum of actin assembly, dynamin 2 induces a less than 30% increase in the cortactin activity under an optimal condition (Schafer et al., 2002) . In the case of Fdg1, a peptide of Fdg1-PRD itself is unable to activate cortactin. However, a GST-Fdg1-PRD fusion protein shows a potential to activate cortactin in an efficiency similar to dynamin 2 (Kim et al., 2004) . As GST is known to form a stable dimer (Weiss et al., 1992) , the apparent effect of GST-Fdg1-PRD was thought to be the result of a possible dimerization of cortactin induced by the GST fusion. We have frequently observed that cortactin mutant with deletion of the SH3 domain showed a slight increase (B30%) as compared to wild type cortactin (Figure 4a , data not shown), suggesting that the SH3 domain may impose a weak self-inhibition to the function of cortactin. Therefore, it is more likely that dynamin 2 or GST-Fdg1-PRD promotes the cortactin's activity simply by blocking this potential autoinhibition on the SH3 domain. In contrast, MIMinduced cortactin activation is quite substantial because it is able to enhance actin polymerization by more than threefold (Figure 3b ). This suggests that MIM may activate cortactin by a mechanism(s) involving other functions that need to be further characterized. One possible function is that full-length MIM has an F-actin binding activity (data not shown), which may facilitate cortactin-mediated actin polymerization. Consistent with this view, WIP, which is able to activate cortactin by nearly twofolds (Kinley et al., 2003) , also shows an F-actin binding activity (Martinez-Quiles et al., 2001) .
Full-length MIM also differs from MIM-CT at its binding to cortactin and activation of cortactinmediated actin polymerization. Although MIM-CT contains a PRD for cortactin, His-MIM-CT binds to cortactin poorly with a K d of 3.7 mM (Figure 4c ) and is unable to precipitate cortactin in a convenient pulldown assay (data not shown). Interestingly, MIM-CT tagged by GST binds strongly to cortactin with an affinity of 1.1 mM and is able to pull down readily cortactin (data not shown). This suggests that His-MIM-CT may not be correctly folded with respect to the function of PRD. One possibility is that the correct folding of MIM requires dimerization because GST is a dimer. While it is unclear whether full-length MIM also assumes a dimeric form, our data indicate that working on a full-length form is necessary to characterize the complete function of MIM. It is interesting to note that His-MIM-CT is still able to inhibit actin polymerization at high concentrations, indicating that its WH2 domain, which locates at the C-terminus, is functional. Since His-MIM-CT is a short splicing variant, the isoform may acquire a unique function that interferes with specifically WASP-related proteins.
